# K230429: Tigertriever 21 Revascularization Device, Tigertriever 17 Revascularization Device, Tigertriever 13 Revascularization Device

- Pathway: 510(k) (Special)
- Applicant: Rapid Medical, Ltd.
- Decided: Apr 17, 2023 after 59 days
- Product code: NRY (Catheter, Thrombus Retriever)
- Device class: 2
- Regulation: 21 CFR 870.1250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 10 generations back to K003410 (2001). 16 ancestors in all.
No later device cites it as a predicate yet.
0 of 17 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K203592: Tigertriever and Tigertriever 17 Revascularization Devce, Rapid Medical, Ltd. (2021) Summary page 4.
- K220808: Tigertriever 13 Revascularization Device, Rapid Medical, Ltd. (2022) Summary page 4.

## Indications for use
The Tigertriever Revascularization Device is intended to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing ischemic stroke within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA), or who fail IV t-PA therapy, are candidates for treatment.

Source page: https://510kreport.com/device/K230429
Methodology: https://510kreport.com/methodology